Technical Research Associate - AI
Keywords Studios- Full Time
- Junior (1 to 2 years)
Candidates should possess a Bachelor's degree in Computer Science, Engineering, or a related field, or equivalent experience. They must have at least two years of extensive software development experience with a strong understanding of front-end and back-end technologies, and one year of experience with AI-driven solutions in enterprise software applications. Prior experience with Interactive Response Technology (IRT) platforms or systems is highly preferred. Strong programming skills in languages like Python, .Net, Java, and JavaScript are also required, along with hands-on experience with AI tools and frameworks such as Hugging Face and OpenAI, and proficiency in prompt engineering.
The Associate Software Developer – AI will develop and present proof of concepts (POCs) to demonstrate the feasibility and value of AI-driven solutions, implement AI-driven solutions at scale across the organization ensuring consistency and alignment with global standards, maintain and enhance deployed solutions by responding to user requests and implementing updates, and support new requirements by upgrading the solution and ensuring its availability. Additionally, the role involves keeping abreast of the latest AI developments, ideating new AI-driven solutions, and presenting them to senior management for review.
Provides interactive response technology for clinical trials
Endpoint Clinical provides interactive response technology (IRT) systems designed for clinical trials. Their systems assist with various trial processes such as managing drug supplies, randomizing patients, and scheduling visits. These systems are user-friendly and cater to clients in the life sciences sector, including pharmaceutical and biotechnology companies. Endpoint Clinical differentiates itself by focusing on ease of use and integration with other clinical trial management systems, ensuring that clients can streamline their processes and maintain regulatory compliance. The company's goal is to enhance the efficiency and transparency of clinical trials, allowing sponsors to conduct their research more effectively.